FI801429A - Benzenimidazolderivat deras framstaellning och anvaendning samt dessa derivat innehaollande kompositioner - Google Patents

Benzenimidazolderivat deras framstaellning och anvaendning samt dessa derivat innehaollande kompositioner

Info

Publication number
FI801429A
FI801429A FI801429A FI801429A FI801429A FI 801429 A FI801429 A FI 801429A FI 801429 A FI801429 A FI 801429A FI 801429 A FI801429 A FI 801429A FI 801429 A FI801429 A FI 801429A
Authority
FI
Finland
Prior art keywords
benzenimidazolderivat
kompositioner
innehaollande
derivat
deras framstaellning
Prior art date
Application number
FI801429A
Other languages
English (en)
Finnish (fi)
Inventor
Claude Gillet
Joseph Roba
Michel Snyers
William Van Dorsser
Georges Lambelin
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of FI801429A publication Critical patent/FI801429A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
FI801429A 1979-05-04 1980-05-02 Benzenimidazolderivat deras framstaellning och anvaendning samt dessa derivat innehaollande kompositioner FI801429A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU81225 1979-05-04

Publications (1)

Publication Number Publication Date
FI801429A true FI801429A (fi) 1980-11-05

Family

ID=19729148

Family Applications (2)

Application Number Title Priority Date Filing Date
FI801428A FI801428A (fi) 1979-05-04 1980-05-02 Fenyletylaminderivat deras framstaellning och anvaendning samt dessa derivat innehaollande kompositioner
FI801429A FI801429A (fi) 1979-05-04 1980-05-02 Benzenimidazolderivat deras framstaellning och anvaendning samt dessa derivat innehaollande kompositioner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI801428A FI801428A (fi) 1979-05-04 1980-05-02 Fenyletylaminderivat deras framstaellning och anvaendning samt dessa derivat innehaollande kompositioner

Country Status (22)

Country Link
US (1) US4338330A (de)
JP (2) JPS565465A (de)
AT (2) AT376210B (de)
AU (2) AU542596B2 (de)
BE (2) BE883069A (de)
CA (1) CA1146563A (de)
CH (2) CH644599A5 (de)
DE (2) DE3016828A1 (de)
DK (2) DK187880A (de)
ES (2) ES8104245A1 (de)
FI (2) FI801428A (de)
FR (2) FR2455572B1 (de)
GB (2) GB2055360B (de)
GR (2) GR68536B (de)
IE (1) IE50218B1 (de)
IL (2) IL59973A (de)
IT (2) IT1150018B (de)
NL (2) NL8002568A (de)
NO (2) NO150916C (de)
PT (2) PT71174A (de)
SE (2) SE8003278L (de)
ZA (2) ZA802694B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1156661A (en) * 1980-02-25 1983-11-08 Hoffmann-La Roche Limited Phenoxy-aminopropanol derivatives
JPS582343A (ja) * 1981-06-30 1983-01-07 Osaka Soda Co Ltd 耐窒素酸化物性に優れた加硫性ゴム組成物
GB8310556D0 (en) * 1983-04-19 1983-05-25 Beecham Group Plc Compounds
US4550119A (en) * 1983-05-23 1985-10-29 Warner-Lambert Company 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones
US5104892A (en) * 1989-12-11 1992-04-14 American Home Products Corporation Substituted benzimidazole derivatives possessing Class III antiarrhythmic activity
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
EP1487843A4 (de) * 2002-03-20 2010-03-10 Metabolex Inc Substituierte phenylessigsäuren
US7351719B2 (en) 2002-10-31 2008-04-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
US7199259B2 (en) * 2003-06-20 2007-04-03 Metabolex, Inc. Resolution of α-(phenoxy)phenylacetic acid derivatives
CA2567437A1 (en) * 2004-05-25 2005-12-08 Metabolex, Inc. Substituted triazoles as modulators of ppar and methods of their preparation
JP2008500358A (ja) * 2004-05-25 2008-01-10 メタボレックス インコーポレーティッド Ｐｐａｒのモジュレーターとしての、二環式の置換されたトリアゾール、およびこれらの調製方法
US7714131B2 (en) * 2005-09-23 2010-05-11 Metabolex, Inc. Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
EP2727911B1 (de) * 2012-10-31 2016-12-21 Medizinische Hochschule Hannover Neuartiges Mittel und neuartige Verfahren zur Behandlung von Malaria und anderen parasitären Krankheiten

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157556A (en) * 1966-06-09 1969-07-09 Egyt Gyogyszervegyeszeti Gyar Novel Benzazole Derivatives and the Preparation thereof
FR1570892A (de) * 1968-06-18 1969-06-13
US3574218A (en) * 1969-08-11 1971-04-06 Egyt Gyogyszervegyeszeti Gyar 2-aryl- or aralkyl-substituted benzazole derivatives
JPS5231858B1 (de) * 1969-12-17 1977-08-17
CH624395A5 (de) 1976-01-08 1981-07-31 Ciba Geigy Ag
DE2609645A1 (de) 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
DE2640730C2 (de) * 1976-09-10 1983-08-25 Hoechst Ag, 6230 Frankfurt Benzoxazolyloxy- und Benzothiazolyloxy-phenoxy-Verbindungen und diese enthaltende herbizide Mittel
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
DE2737630A1 (de) 1977-08-20 1979-03-01 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2801953A1 (de) 1978-01-18 1979-07-19 Boehringer Mannheim Gmbh 4-hydroxy-2-benzimidazolinon-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE2801980A1 (de) 1978-01-18 1979-07-19 Boehringer Mannheim Gmbh 4-hydroxy-2-benzimidazolin-thion- derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
EP0003758A1 (de) 1978-02-09 1979-09-05 Ciba-Geigy Ag Verätherte Hydroxy-benzodiheterocyclen und ihre Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE2905877A1 (de) 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2905876A1 (de) 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue piperidinopropylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
ES491142A0 (es) 1981-03-16
FR2455572A1 (fr) 1980-11-28
IT8021780A0 (it) 1980-05-02
PT71175A (fr) 1980-05-01
JPS565465A (en) 1981-01-20
BE883068A (fr) 1980-08-18
AT376418B (de) 1984-11-26
IT1159060B (it) 1987-02-25
CH644599A5 (fr) 1984-08-15
ZA802694B (en) 1981-08-26
ES8103729A1 (es) 1981-03-16
NO801285L (no) 1980-11-05
ZA802695B (en) 1981-08-26
DE3016827A1 (de) 1980-11-20
GB2055091B (en) 1983-11-09
SE8003277L (sv) 1980-11-05
DK187980A (da) 1980-11-05
ES491143A0 (es) 1981-04-16
IT1150018B (it) 1986-12-10
FR2455587A1 (fr) 1980-11-28
BE883069A (fr) 1980-08-18
DE3016828A1 (de) 1980-11-13
AU542596B2 (en) 1985-02-28
DK187880A (da) 1980-11-05
NO150916C (no) 1985-01-16
IL59974A0 (en) 1980-07-31
IT8021780A1 (it) 1981-11-02
SE8003278L (sv) 1980-11-05
ATA238780A (de) 1984-03-15
GB2055091A (en) 1981-02-25
ATA238680A (de) 1984-04-15
NL8002567A (nl) 1980-11-06
GB2055360B (en) 1983-07-06
AU5809580A (en) 1980-11-06
IT8021779A1 (it) 1981-11-02
US4338330A (en) 1982-07-06
GR68536B (de) 1982-01-18
JPS5663946A (en) 1981-05-30
PT71174A (fr) 1980-05-01
NO150916B (no) 1984-10-01
NO801286L (no) 1980-11-05
IE800918L (en) 1980-11-04
FI801428A (fi) 1980-11-05
CH645090A5 (fr) 1984-09-14
FR2455587B1 (de) 1983-06-24
IL59973A (en) 1985-03-31
CA1146563A (en) 1983-05-17
IE50218B1 (en) 1986-03-05
GR68535B (de) 1982-01-18
JPS6033424B2 (ja) 1985-08-02
AT376210B (de) 1984-10-25
NL8002568A (nl) 1980-11-06
AU5809680A (en) 1980-11-06
IT8021779A0 (it) 1980-05-02
GB2055360A (en) 1981-03-04
IL59973A0 (en) 1980-07-31
ES8104245A1 (es) 1981-04-16
AU537573B2 (en) 1984-07-05
FR2455572B1 (fr) 1986-07-25

Similar Documents

Publication Publication Date Title
FI802907A (fi) Koherent fasdemodulator samt ledningsbundet kommunikationssystem daer densamma tillaempas
FI802177A (fi) Cylinderlaos nyckel foer laoset samt foerfarande foer framstaellning av nyckeln
FI802178A (fi) Cylinderlaos-nyckel-kombination nyckel foer laoset samt foerfarande foer framstaellning av nyckeln
FI803558L (fi) 7-acylamino-3-vinylcefalosporansyraderivat och foerfarande foer deras framstaellning
FI800972A (fi) Adsorbensfraktioneringsapparat med elektroniskt sekvensur och cykelkontroll samt process
FI802590A (fi) Clavulansyrasalter foerfarande foer framstaellning och anvaendning daerav
FI800046A (fi) 2-penem-foereningar och foerfarande foer deras framstaellning
FI793667A (fi) Kontaktlimkomposition och daerav framstaelld tejp
FI802905A (fi) Karbostyrilderivat foerfarande foer deras framstaellning och dessa innehaollande saosom antihistamin verkande aemnen
FI801020A (fi) 5-substituerade pyranon-foereningar och deras anvaendning saosom laekemedelsprodukter
FI801099A (fi) Polyen-makrolid-antibiotika-amider och deras derivat samt foerfarande foer framstaellning av dem
FI793282A (fi) Kugghjulspump och/eller -motor
FI801429A (fi) Benzenimidazolderivat deras framstaellning och anvaendning samt dessa derivat innehaollande kompositioner
FI802951A (fi) Mesofasloesning innehaollande cellulosaderivat och oorganisk syra
FI800605A (fi) Baelte samt framstaellningsfoerfarande
FI802332A (fi) N-glykocylderivat av antracyklina antibioter samt deras framstaellningsfoerfarande
FI801839A (fi) Haengklaemma foer isolerade ledare och ledarknippen
FI801518A (fi) Prefabricerad laboratorie-enhet och oktananalysator
FI790022A (fi) Anordning foer maetning av kyleffektbehovet foer kylt utrymme samt av kylmaskineriets kyleffekt
FI803030A (fi) Dibensazepinderivat deras framstaellning och farmaceutiska sammansaettningar innehaollande dessa
FI801019A (fi) 6-substituerade pyranon-foereningar och deras anvaendning saosom laekemedelsprodukter
FI800883A (fi) Ytaktiva fosfonsyraestrar och dessa innehaollande polymerdispersioner och -emulsioner
FI813827L (fi) Foerfarande och anordning foer varmbearbetning
FI803666L (fi) Sjaelvborrande skruv och fraesverktyg foer tillverkning daerav
FI802653A (fi) Lignocellulosamaterial med foerbaettrad styrka avvattningsfoermaoga och malbarhet samt saett att framstaella detta

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: CONTINENTAL PHARMA